Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010, Article ID 938408, 6 pages
http://dx.doi.org/10.1155/2010/938408
Clinical Study

Elevated Adiponectin Serum Levels in Women with Systemic Autoimmune Diseases

1Department of Rheumatology, University Hospital Jean Minjoz, Bd Fleming, 25030 Besançon Cedex, France
2University Hospital St Jacques, CIC Biotherapy-CBT 506, 25030 Besançon Cedex, France
3University of Franche Comté, Équipe d'Accueil 4266 “Agents Pathogènes et Inflammation”, IFR133, 25000 Besançon, France
4INSERM UMR645, 1 Bd A Fleming, 25020 Besançon Cedex, France
5University of Franche-Comté, UMR645, IFR133, 25020 Besançon Cedex, France
6EFS Bourgogne Franche-Comté, Plateforme de Biomonitoring, 25020 Besançon Cedex, France
7Department of Physiology, University Hospital Jean Minjoz, Bd Fleming, 25030 Besançon Cedex, France
8University of Franche Comté, Équipe d'Accueil EA 3920 “Physiopathologie Cardiovasculaire et Prévention”, IFR133, 25000 Besançon, France

Received 20 April 2010; Revised 14 September 2010; Accepted 7 November 2010

Academic Editor: Oreste Gualillo

Copyright © 2010 Éric Toussirot et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Fantuzzi, “Adipose tissue, adipokines, and inflammation,” Journal of Allergy and Clinical Immunology, vol. 115, no. 5, pp. 911–920, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. E. Toussirot, G. Streit, and D. Wendling, “The contribution of adipose tissue and adipokines to inflammation in joint diseases,” Current Medicinal Chemistry, vol. 14, no. 10, pp. 1095–1100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Lago, C. Dieguez, J. Gómez-Reino, and O. Gualillo, “Adipokines as emerging mediators of immune response and inflammation,” Nature Clinical Practice Rheumatology, vol. 3, no. 12, pp. 716–724, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. M. Otero, R. Lago, R. Gomez, C. Dieguez, F. Lago, J. Gómez-Reino, and O. Gualillo, “Towards a pro-inflammatory and immunomodulatory emerging role of leptin,” Rheumatology, vol. 45, no. 8, pp. 944–950, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. G. Fantuzzi, “Adiponectin and inflammation: consensus and controversy,” Journal of Allergy and Clinical Immunology, vol. 121, no. 2, pp. 326–330, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. A. Garcia-Gonzalez, L. Gonzalez-Lopez, and L. Gonzalez-Lopez, “Serum leptin levels in women with systemic lupus erythematosus,” Rheumatology International, vol. 22, no. 4, pp. 138–141, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. K. E. Sada, Y. Yamasaki, M. Maruyama, H. Sugiyama, M. Yamamura, Y. Maeshima, and H. Makino, “Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus,” Journal of Rheumatology, vol. 33, no. 8, pp. 1545–1552, 2006. View at Google Scholar · View at Scopus
  8. C. P. Chung, A. G. Long, J. F. Solus, Y. H. Rho, A. Oeser, P. Raggi, and C. M. Stein, “Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis,” Lupus, vol. 18, no. 9, pp. 799–806, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. Vadacca, D. Margiotta, A. Rigon, F. Cacciapaglia, G. Coppolino, A. Amoroso, and A. Afeltra, “Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors,” Journal of Rheumatology, vol. 36, no. 2, pp. 295–297, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. M. Wislowska, M. Rok, K. Stepien, and A. Kuklo-Kowalska, “Serum leptin in systemic lupus erythematosus,” Rheumatology International, vol. 28, no. 5, pp. 467–473, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. J. B. De Sanctis, M. Zabaleta, N. E. Bianco, J. V. Garmendia, and L. Rivas, “Serum adipokine levels in patients with systemic lupus erythematosus,” Autoimmunity, vol. 42, no. 4, pp. 272–274, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. E. Toussirot, C. Salmon, A. Penfornis, and D. Wendling, “Precision evaluation of Lunar iDXA body composition measurements,” Journal of Bone and Mineral Research, vol. 22, supplement, p. S300, 2007. View at Google Scholar
  13. D. R. Matthews, J. P. Hosker, and A. S. Rudenski, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Google Scholar
  14. C. C. Mok, C. H. To, and K. M. Ma, “Changes in body composition after glucocorticoid therapy in patients with systemic lupus erythematosus,” Lupus, vol. 17, no. 11, pp. 1018–1022, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. K. C. Lewandowski, K. Szosland, and A. Lewinski, “Short-term dexamethasone administration does not alter serum adiponectin or resistin concentrations in overweight and obese subjects despite an increase in insulin resistance,” Clinical Endocrinology, vol. 65, no. 4, pp. 551–552, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. M. K. Vihinen, K. L. Kolho, O. A. Jänne, S. Andersson, and T. Raivio, “Circulating adiponectin as a marker for glucocorticoid-related side effects in children and adolescents with inflammatory bowel disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 48, no. 4, pp. 504–506, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. T. B. Laurberg, J. Frystyk, and J. Frystyk, “Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naïve compared with patients with osteoarthritis and controls,” Journal of Rheumatology, vol. 36, no. 9, pp. 1885–1891, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. N. Kusunoki, K. Kitahara, and K. Kitahara, “Adiponectin stimulates prostaglandin E production in rheumatoid arthritis synovial fibroblasts,” Arthritis and Rheumatism, vol. 62, no. 6, pp. 1641–1649, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. C. H. Tang, Y. C. Chiu, T. W. Tan, R. S. Yang, and W. M. Fu, “Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-κB pathway,” Journal of Immunology, vol. 179, no. 8, pp. 5483–5492, 2007. View at Google Scholar · View at Scopus
  20. K. Ebina, A. Fukuhara, and A. Fukuhara, “Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction,” Clinical Rheumatology, vol. 28, no. 4, pp. 445–451, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. Y. Okamoto, S. Kihara, T. Funahashi, Y. Matsuzawa, and P. Libby, “Adiponectin: a key adipocytokine in metabolic syndrome,” Clinical Science, vol. 110, no. 3, pp. 267–278, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. N. Hattori, “Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system,” Growth Hormone and IGF Research, vol. 19, no. 3, pp. 187–197, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. M. Delgado and D. Ganea, “Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents,” Brain, Behavior, and Immunity, vol. 22, no. 8, pp. 1146–1151, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. M. Otero, R. Nogueiras, F. Lago, C. Dieguez, J. J. Gomez-Reino, and O. Gualillo, “Chronic inflammation modulates ghrelin levels in humans and rats,” Rheumatology, vol. 43, no. 3, pp. 306–310, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. E. Toussirot, G. Streit, N. U. Nguyen, G. Dumoulin, G. Le Huédé, P. Saas, and D. Wendling, “Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis,” Metabolism: Clinical and Experimental, vol. 56, no. 10, pp. 1383–1389, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus